Abcellera Biologics Inc
NASDAQ:ABCL

Watchlist Manager
Abcellera Biologics Inc Logo
Abcellera Biologics Inc
NASDAQ:ABCL
Watchlist
Price: 2.64 USD -2.94% Market Closed
Market Cap: 777.9m USD
Have any thoughts about
Abcellera Biologics Inc?
Write Note

Abcellera Biologics Inc
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Abcellera Biologics Inc
Accounts Receivables Peer Comparison

Comparables:
ARCH
RP
IOT

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Abcellera Biologics Inc
NASDAQ:ABCL
Accounts Receivables
$30.6m
CAGR 3-Years
-48%
CAGR 5-Years
107%
CAGR 10-Years
N/A
Arch Biopartners Inc
XTSX:ARCH
Accounts Receivables
CA$967.5k
CAGR 3-Years
-21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Replicel Life Sciences Inc
XTSX:RP
Accounts Receivables
CA$35.4k
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innovotech Inc
XTSX:IOT
Accounts Receivables
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Abcellera Biologics Inc's Accounts Receivables?
Accounts Receivables
30.6m USD

Based on the financial report for Dec 31, 2023, Abcellera Biologics Inc's Accounts Receivables amounts to 30.6m USD.

What is Abcellera Biologics Inc's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
107%

Over the last year, the Accounts Receivables growth was -21%. The average annual Accounts Receivables growth rates for Abcellera Biologics Inc have been -48% over the past three years , 107% over the past five years .

Back to Top